The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
2020 · Scientific Reports · 107 citations
https://doi.org/10.1038/s41598-020-66458-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
728
Citations
13
h-index
14
i10-index
Binu K. Philip is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Monoclonal and Polyclonal Antibodies Research & Bone Metabolism and Diseases. The author has an h-index of 13, co-authored 23 publications.
https://doi.org/10.1038/s41598-020-66458-z
https://doi.org/10.1016/j.omtm.2020.08.017
Click to start Chat